CDW Corp. vs Inovio Pharmaceuticals Inc — how do they compare? CDW Corp. trades at $135 (market cap $16.92B), while Inovio Pharmaceuticals Inc trades at $0.77 (market cap $78.55M). The key difference: CDW Corp. is far larger — about 215.4× Inovio Pharmaceuticals Inc's market cap, and CDW Corp. pays a 1.86% dividend while Inovio Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| CDW | INO | |
|---|---|---|
Market Cap | $16.92B | $78.55M |
Sector | Technology | Health |
52-Week High | $170.77 | $2.87 |
52-Week Low | $99.30 | $0.66 |
Enterprise Value | $22.52B | $49.56M |
Dividend Yield | 1.86% | — |
Trailing returns across standard periods
Latest headlines on both assets
CDW Corp is a value-added reseller operating in the U.S. (95% of sales) and Canada (5%). The company has more than 100,000 products on its line of cards that range from notebooks to data center software. Roughly half of CDW's revenue comes from midsize and large businesses, with the remaining from small businesses, government agencies, education institutions, and health-care organizations.
Read more on CDW →Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →